Skip to search formSkip to main contentSkip to account menu

CP-675,206

Known as: CP 675206, CP-675206, CP675206 
National Institutes of Health

Related topics

Related topics

2 relations
ipilimumab

Broader (1)

tremelimumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
A phase I dose escalation trial of CP-675206 (tremelimumab) in combination with gemcitabine in patients with chemotherapy-naive metastatic pancreatic cancer.
4134 Background: CP-675,206 (tremelimumab) is a fully human monoclonal antibody which binds to the CTLA4 molecule on the surface… 
2005
2005
CP 675206 offers hope to patients with melanoma
  • 2005
  • Corpus ID: 195103494
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)